The Effects of Nanomicelles Curcumin on Glycemic Control, Serum Lipid Profile ,Blood Pressure and Anthropometric Measurements in Patients With Metabolic Syndrome

National Nutrition and Food Technology Institute

Status

Unknown

Conditions

Metabolic Syndrome

Treatments

Dietary Supplement: placebo

Dietary Supplement: nanomicielle curcumin

Study type

Interventional

Funder types

Other

Identifiers

NCT03534024

207

Details and patient eligibility

About

Metabolic syndrome is a condition which is recognized by abdominal obesity, dyslipidemia, hyperglycemia, and hypertension. Curcumin has beneficial effects such as antioxidant and anti-inflammatory effects. nanomcielle curcumin will be used in this study because of the low bioavailability , fast metabolism and low absorption of curcumin powder. Therefore, this study is planned to determine the effects of supplementation of nanomicelle curcumin on glycemic control, serum lipid profile ,blood pressure and anthropometric measurements in patients with metabolic syndrome.

Enrollment

50 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

25<body mass index >40
waist circumference >102 cm in men or >88 cm in women
Fasting blood glucose >100 mg/dL
Triglycerides (TG) > 150 mg/dL
High density lipoprotein cholesterol (HDL-C) <50 in women or <40 in men
Systolic blood pressure (SBP) >130 mmHg and diastolic blood pressure (DBP) >85mmHg

Exclusion criteria